GlassScriptPhysician profile
Stacy Ulmer-Pinter
NPI 1316031040
$8,063.41
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $557 · 2021: $239 · 2022: $6,366 · 2023: $14.87 · 2024: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $106 · Food and Beverage: $14.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $106.35 |
| Food and Beverage | $14.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,472.38 | 2022-2024 | |
| Abbvie INC. | $523.28 | 2019-2021 | |
| Hologic Sales and Service, LLC | $160.16 | 2019-2020 | |
| Novo Nordisk INC | $138.54 | 2020-2021 | |
| Pfizer INC. | $127.69 | 2019-2021 | |
| Lupin INC. | $119.63 | 2019 | |
| Duchesnay USA Incorporated | $118.67 | 2019 | |
| Merck Sharp & Dohme LLC | $111.42 | 2019-2021 | |
| Therapeuticsmd, INC. | $85.23 | 2019-2021 | |
| Allergan, INC. | $56.19 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $20.95 | 2019 | |
| Eisai INC. | $19.90 | 2020 | |
| Agile Therapeutics, INC. | $19.48 | 2021 | |
| Evofem Biosciences, INC. | $18.81 | 2021 | |
| Amag Pharmaceuticals, INC. | $17.71 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $15.12 | 2021 | |
| Applied Medical Resources Corporation | $14.87 | 2023 | |
| Avion Pharmaceuticals | $13.80 | 2019 | |
| Kinex Medical Company LLC | $9.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Ulmer-Pinter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.